{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:09:16Z","timestamp":1780538956155,"version":"3.54.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.cardfail.2007.04.004","type":"journal-article","created":{"date-parts":[[2007,9,8]],"date-time":"2007-09-08T11:19:13Z","timestamp":1189250353000},"page":"556-559","source":"Crossref","is-referenced-by-count":62,"title":["A 6-Month Follow-up of Intermittent Levosimendan Administration Effect on Systolic Function, Specific Activity Questionnaire, and Arrhythmia in Advanced Heart Failure"],"prefix":"10.1016","volume":"13","author":[{"given":"Sophie","family":"Mavrogeni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Giamouzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Papadopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Thomopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Dritsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Athanasopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Adreanides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Vassiliadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Spargias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimosthenis","family":"Panagiotakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis V.","family":"Cokkinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2007.04.004_bib1","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1517\/14656566.6.15.2741","article-title":"Levosimendan for the treatment of acute heart failure syndromes","volume":"6","author":"Parissis","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.cardfail.2007.04.004_bib2","first-page":"120","article-title":"Effects of levosimendan on myocardial contractility and oxygen consumption","volume":"279","author":"Todaka","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cardfail.2007.04.004_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/0091270002042001005","article-title":"Pharmacodynamics and safety of a new calcium sensitizer, levosimendan, and its metabolites during an extended infusion in patients with severe heart failure","volume":"42","author":"Kiviko","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.cardfail.2007.04.004_bib4","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1161\/01.CIR.98.20.2141","article-title":"Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium","volume":"98","author":"Hasenfuss","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2007.04.004_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-2999(97)01108-4","article-title":"Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide- sensitive K+ channel in rat arterial myocytes","volume":"333","author":"Yokoshiki","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.cardfail.2007.04.004_bib6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0140-6736(02)09455-2","article-title":"Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study: a randomized double-blind trial)","volume":"360","author":"Follath","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2007.04.004_bib7","doi-asserted-by":"crossref","first-page":"80G","DOI":"10.1016\/j.amjcard.2005.07.025","article-title":"European experience on the practical use of levosimendan in patients with acute heart failure syndromes","volume":"96","author":"Follath","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2007.04.004_bib8","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.amjcard.2004.07.128","article-title":"Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone","volume":"94","author":"Nanas","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2007.04.004_bib9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/01.CIR.0000043245.00859.11","article-title":"Sustained hemodynamic effects of intravenous levosimendan","volume":"107","author":"Kiviko","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2007.04.004_bib10","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ijcard.2004.12.046","article-title":"Activity questionnaires; a useful tool in accessing heart failure patients","volume":"105","author":"Chryssanthopoulos","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2007.04.004_bib11","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.amjcard.2004.01.073","article-title":"Effects of levosimendan on circulating proinflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure","volume":"93","author":"Parissis","year":"2004","journal-title":"Am J Cardiol"},{"issue":"Suppl 2","key":"10.1016\/j.cardfail.2007.04.004_bib12","first-page":"45S","article-title":"Preliminary clinical experience with the repetitive administration of levosimendan in patients with end-stage heart failure","volume":"4","author":"Spargias","year":"2003","journal-title":"Ital Heart J"},{"key":"10.1016\/j.cardfail.2007.04.004_bib13","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1161\/01.CIR.102.18.2222","article-title":"Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure","volume":"102","author":"Slawsky","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2007.04.004_bib14","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0735-1097(00)00961-X","article-title":"Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure","volume":"36","author":"Nieminen","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2007.04.004_bib15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0014-2999(00)00609-9","article-title":"Levosimendan improves diastolic and systolic function in failing human myocardium","volume":"404","author":"Janssen","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.cardfail.2007.04.004_bib16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0002-9149(99)00313-6","article-title":"Effects of levosimendan on cardiac arrhythmia: electrophysiologic and ambulatory electrocardiographic findings in phase II and phase III clinical studies in cardiac failure","volume":"83","author":"Singh","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2007.04.004_bib17","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1136\/hrt.2006.079707","article-title":"Effects of serial levosimendan infusions on left ventricular performance and plasma biomarkers of myocardial injury and neurohormonal and immune activation in patients with advanced heart failure","volume":"92","author":"Parissis","year":"2006","journal-title":"Heart"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916407001327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916407001327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T07:52:53Z","timestamp":1546588373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916407001327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S1071916407001327"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2007.04.004","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}